{Reference Type}: Letter
{Title}: Risankizumab effectiveness and safety in psoriasis patients who failed other biologics: Real-life case series.
{Author}: Dawoud NM;El Badawy MB;Al Eid HS;Abdel Fattah MM;
{Journal}: Indian J Dermatol Venereol Leprol
{Volume}: 88
{Issue}: 2
{Year}: Mar-Apr 2022
{Factor}: 2.217
{DOI}: 10.25259/IJDVL_510_2021
{Abstract}: